SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling.
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
up- or down-regulation of SLC25A18. Immunohistochemical staining of SLC25A18 was performed on a tissue microarray of 106 patients with primary or metastatic CRC to evaluate its predictive and prognostic value. SLC25A18 expression was low in the CRC samples and was negatively correlated with stage, age and serum carcinoembryonic antigen levels. High expression of SLC25A18 indicated longer disease-free survival time after surgery. Exogenous overexpression of SLC25A18 decreased glucose consumption, lactate production, intracellular ATP concentration and cell proliferation and abrogated expression of CTNNB1, PKM2, LDHA and MYC. Inhibition of Wnt/β-catenin restored SLC25A18-repressed cellular activities. SLC25A18 clinically predicted a longer survival time after surgery or medicine treatment. These results showed that increased SLC25A18 expression inhibits Warburg effect and cell proliferation via Wnt/β-catenin cascade, and suggest a better prognosis after treatment.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
Où se fait cette recherche
-
Shanghai Medical College of Fudan University pays non établi dans la noticeUniversité ou école supérieure
-
Fudan University Department of Medical Oncology pays non établi dans la noticeUniversité ou école supérieure
-
Zhongshan Hospital pays non établi dans la noticeÉtablissement de santé
Shanghai Medical College of Fudan University, Department of Medical Oncology — Fudan University et Zhongshan Hospital.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.